Detalles de la búsqueda
1.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Eur J Haematol
; 108(5): 437-445, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35122325
2.
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Br J Haematol
; 181(6): 782-790, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29741758
3.
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Biol Blood Marrow Transplant
; 21(8): 1437-44, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25865648
4.
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
Br J Haematol
; 158(2): 174-185, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22640008
5.
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 16(5): 639-46, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20005967
6.
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Biol Blood Marrow Transplant
; 15(2): 205-13, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19167680
7.
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Clin Lymphoma Myeloma Leuk
; 18(11): e481-e491, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30100330
8.
Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.
Leuk Lymphoma
; 58(2): 324-332, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27347845
9.
Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.
Clin Lymphoma Myeloma Leuk
; 15(6): 341-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25656914
10.
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.
Leuk Lymphoma
; 53(7): 1321-6, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22192245
11.
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).
Leuk Lymphoma
; 52(1): 34-41, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21133716
12.
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels.
Leuk Res
; 33(2): 271-5, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18762338
13.
Disseminated mucormycosis presenting as transplant-associated thrombotic microangiopathy.
Leuk Res
; 35(7): e138-40, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21514669
Resultados
1 -
13
de 13
1
Próxima >
>>